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Venom from the reptile Bothrops atrox can convert 
plasma fibrinogen into fibrin and induce platelet 
aggregation [l-3 1. Each activity is attributed to a 
distinct serine protease isolated from the venom: 
batroxobin [l] ( or reptilase) and thrombocytin [2,3]. 
Purified batroxobin can generate fibrin by hydrolysis 
of fibrinogen, yet is incapable of causing platelet 
a@regation El]. Conversely, thrombocytin induces 
platelet aggregation, but has very limited, if any, abil- 
ity to convert ~b~nogen i to fibrin [2,3f. Here we 
report that Bothrops atrox venom also contains a 
lectin which we have designated thrombolectin. This 
lectin is a disulfide-linked, imeric protein of apparent 
monomer mol. wt -15 000. The activity of the lectin 
is inhibited maximally by P-galactosides and, in con- 
trast to other galactolectins [4], is calciumdependent 
and inhibited by reducing agents. 
2, Mater&Is and methods 
2.1. . Mate~~s 
Thrombocytin, reptiiase@ and Chromozym TH were 
supplied by Pentapharm Ltd., Basle. The thrombocytin 
was purified as in [2]. Fetuin, diisopropyl phospho- 
fluoridate (DFP), thiodigalactoside, and the other sug- 
ars were obtained from Sigma Chemical Co. St Louis. 
2.2. Methods 
Thrombocytin amidolytic activity was assayed as 
in [2] using Chromozym TH as substrate. The eryth- 
rocytes were prepared and the microtiter hemag- 
~ut~ation assays run as in fs] except hat Tyrode 
buffer (1 g glucose, 8 g NaCl, 1 g NafICOs, 0.2 g 
CaC12, 0.1 g MgClz -6 H,O, 0.2 g KCl, 0.05 g 
NazHPO+ . 1 HzO/liter, pH 7.4) was used in the plates. 
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A 10 X molar excess of DFP was added (10-200 ~1) 
to thrombocytin in Tris-imidazole-saline buffer 
(0.1 M Trizma base, 0.1 M imidazole and 0.15 M 
NaCl, pH 8.4) [2]. Th e mixture was incubated at room 
temperature for 30 min and assayed without dialysis. 
As a control, tbrombocytin was treated the same way 
except hat no DFP was added. Thrombolectin was 
isolated from Bothrops atrox venom (Pentapharm 
Ltd., Basle) by affmity chromatography using asialo- 
fetuin-Sepharose 4B. Fetuin (150 mg) was desialyzed 
by ~cubation in 10 ml 0.001 M NaH2P04, 0.15 M 
NaCl (pH 2.0) at 80°C for 1 h f6]. The resulting asia- 
lofetuin solution was dialyzed against saline for 24 h 
at 4°C. The asialofetuin was coupled to CNBr-activated 
Sepharose 4B (20 ml packed) prepared by the method 
in [7]. All isolation procedures were done at 4’C. The 
asialofetuin-Sepharose 4Bcolumn was poured and 
equilibrated with Tyrode buffer (pH 7.4). Crude 
venom (200 mg in 4 ml Tyrode buffer) was applied 
to the column, extraneous materials were removed by 
washing with Tyrode buffer. Thrombolectin was eluted 
from the column with 0.05 M l&ose in Tyrode buff- 
er. The purified isolated ~rombole~t~ was dialyzed 
exhaustively against Tyrode buffer at 4°C and stored 
frozen at -12*C until used. Sodium dodecyl sulfate- 
polyacrylamide gel electrophoresis (SDS-PAGE) was 
done as in [S], with a few modifications. SDS-PAGE 
gel slabs containing thrombolectin were stained for 
carbohydrate using the periodic acid8chiffs reagent 
[9]. Protein determinations were made as in [lo]. 
3. Results 
3 .l , Discovery of the he~lu~n~ 
In the course of characterizing the expression of 
the endogenous hemagglutinin [l l] of human plate- 
lets, we discovered that high (120 pg/ml) concentra- 
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tions of thrombocytin [2,3] agglutinated formalde- 
hyde fixed bovine erythrocytes. This hemagglutina- 
tion activity was present in each of 3 thrombocytin 
batches (141104, 161104, 17/104) tested with our 
assay system. In contrast, batroxobin purified from 
the same venom used to prepare batch 17/104 of 
thrombocytin, lacked hemagglutination activity. The 
hemagglutination activity was also present in the crude 
venom. 
3.2. The hemagglu tinin is a lectin 
The hemagglutinin was identified as a lectin by 
demonstrating that its activity was specifically inhib- 
ited by saccharides. Lactose and fl-thiodigalactoside 
(TDG), an analogue of lactose, blocked the activity of 
the lectin, whereas D-glucose, methyl o-D-mannoside, 
D-galactosamine, D-glucosamine, D-mannosamine, 
L-arginine, and L-glutamine had little or no effect on 
the hemagglutination activity of the thrombocytin 
preparations. 
temperature with formaldehyde-futed bovine erythro- 
cytes. The erythrocytes agglutinated and rapidly 
settled out. The cell-free supernatant fraction resulting 
from centrifugation of this material had <3% of the 
original ectin activity and 100% of the original pro- 
teolytic activity. Incubation of the crude venom for 
the same time under the same conditions except hat 
the buffer lacked fKed erythrocytes resulted in no 
loss of either activity. Some of the lectin bound to 
the aggregated f=ed erythrocytes was recovered by 
adding 0.5 M final cont. thiodigalactoside to the 
resuspended rythrocytes presumably containing the 
lectin. The cells were removed and the supernatant 
fraction was dialyzed at 4°C against Tyrode buffer. 
The dialysate contained hemagglutinin activity with 
a high titer but lacked protease activity. Trypsin treat- 
ment of the thrombocytin preparation destroyed its 
lectin activity. These results demonstrate hat the 
lectin activity and the proteolytic activity of the 
thrombocytin preparations were caused by separable 
proteins. 
3.3. The lectin is not thrombocytin 
The hemagglutination a d proteolytic activities of 
thrombocytin preparations were characterized to
determine if thrombocytin was the lectin. Heating the 
thrombocytin preparation at 65°C for 10 min inacti- 
vated >94% of the lectin activity but had no effect on 
the proteolytic activity (table 1). DFP treatment.of 
the thrombocytin preparation destroyed >97% of the 
proteolytic activity but had no effect on the lectin 
activity. Crude venom which had both thrombocytin 
activity and lectin activity was incubated at room 
3.4. Purification and characterization of the lectin 
The lectin was purified using an asialofetuin- 
derivatized Sepharose 4B column, a standard tech- 
nique for purifying galactolectins [6,12] (see sec- 
tion 2). The purified thrombolectin lacked detectable 
(thrombocytin) amidolytic activity. Fig.1 reveals that 
thrombolectin had monomer mol. wt -15 000 on 
SDS-PAGE in the presence of /I-mercaptoethanol. In 
contrast, under non-reducing conditions the predom- 
inant form of thrombolectin was a dimer of mol. wt 
Table 1 
Characterization of the lectin and proteolytic activities of the thrombocytin 
preparations 
Treatment % Protease act. % Lectin act. 
Untreated thrombocytin 
Heat-treated thrombocytin 
DFP-treated thrombocytin 
Trypsin-treated thrombocytin 
100 100 
100 <6 
3 100 
_ 0 
Thrombocytin at 0.25 mg/ml in Tris-imidazole-saline buffer at pH 8.4 was 
heated at 65°C for 10 mm. Trypsin treatment of the thrombocytin was done by 
adding 10 ~11.5 mg trypsin/ml solution in Tyrode buffer to 200 ~10.25 mg 
thrombocytin/ml solution of in Tris-imidazole-saline buffer. The mixture was 
incubated at room temperature for 20 min. A 10 X weight excess of soybean 
trypsin inhibitor was added. As controls, untreated thrombocytin was diluted 
with Tyrode buffer and another aliquot of thrombocytin received trypsin pre- 
treated with soybean trypsin inhibitor. The trypsin-soybean-trypsin inhibitor 
mixture did not inactivate the lectin activity of the thrombocytin preparation 
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- 67,000 
c 
Fig.1. SDS-polyacrylamide gel electrophoresis of thrombo- 
lectin. Samples of isolated thrombolectin were resolved on 
SDS-polyacrylamide gel slabs prepared as exponential gra- 
dients of 5-20% acrylamide. (A) contains 7.6 ccg non-reduced 
purified thrombolectin; (B) contains 7.6 fig purified thrombo- 
lectin fully reduced with 10% p-mercaptoethanol; (C) contains 
6 low molecular weight standards obtained from Bio-Rad 
Labs: phosphorylase b (M, 94 000); albumin (Afr 67 000); 
ovalbumin (M, 43 000); carbonic anhydrase (M, 30 000); 
trYPsm (MI 20 100); cu-lactalbumin (M, 14 400). Coomassie 
brilliant blue was used to stain the resolved proteins. 
-28 000. Our results do not allow us to conclude 
that the dimer was composed of identical subunits 
because on some gels the monomer form appeared as 
two closely migrating bands. Thrombolectin did not 
appear to be a glycoprotein because it gave negative 
reactions to the Schiff’s reagent following treatment 
with periodate. The average specific activity for all 
our assays (pH 7.4) of the purified thrombolectin 
was 86.8 X lo6 (S. A. is the hemagglutination titer/ 
mg protein). Ethylenedinitrilo-tetraacetic a id 
(1 mM) abolished thrombolectin’s hemagglutination 
activity and this inhibition was prevented by calcium. 
Over pH 6.0-9.0, thrombolectin had maximum 
hemagglutination activtiy at pH 6.6. Dithiothreitol 
(2 mM) inhibited 287% of the lectin activity. Hemag- 
glutination was inhibited with decreasing efficiency 
by the following compounds: TDG; lactose; methyl 
fl-D-galactoside; D-galactose; and methyl a-D-galacto- 
side (see table 2). Inhibition of 50% of the maximum 
hemagglutination activity was caused by 0.3 mM 
Table 2 
Saccharide inhibition of thrombolectin hemagglutination 
activity 
Saccharide Concentration that inhibits 50%a 
of maximum activity (mM) 
Thiodigalactoside 0.3 
Lactose 0.8 
Methyl p-Dgalactoside 2.0 
D-&lactose 2.0 
Methyl o-D-gahuztoside 6.0 
Maltose >15 
Sucrose >15 
D-Glucose >15 
D-Mannose >15 
D-Fructose >15 
a DGalactosamme, Dglucosamhre, D-mannosamme, N-acetyl 
glucosamine, methyl a-D-mannoside, arginine, glutamine, 
and lysine also failed to inhibit at 15 mM final cont. 
TDG, 0.8 mM lactose, 2 mM methyl fl-D-galactoside, 
2 mM D-galactose, or 6 mM methyl o-D-galactoside 
(table 2). Thrombolectin was stable during both 
storage at -12°C and overnight incubation at room 
temperature. 
4. Discussion 
These results demonstrate hat the venom of Both- 
raps atrox contains thrombolectin. The hemagglutina- 
tion activity of thrombolectin was Inhibited by TDG, 
lactose, and methyl P-D-galactoside. Therefore, throm- 
bolectin has a similar, though not identical, saccharide 
specificity as a class of lectins (elehrolectins [131 or 
galactolectins [4]) originally isolated from the electric 
organ of the electric eel [ 131 and isolated or identified 
in a variety of rat tissues [131, chick embryonic pec- 
toral and thigh muscles [14-161, brain and liver [17], 
adult chicken liver, pancreas and intestine [18], rat 
myoblasts in tissue culture [ 191, chicken heart and 
calf spleen, thymus, liver, heart [20], and lungs [6]. 
Characterization f galactolectins purified from these 
tissues [12- 14,17,20] demonstrated that they also 
were dimers but differ, in those cases tested, from 
thrombolectin in that they were not calcium-depen- 
dent, required thiol groups for activity, and were 
inhibited more extensively by methyl o-D-galactoside 
than by methyl P-D-galactoside. 
The physiological role(s) of galactolectins is 
unknown. However, evidence obtained using different 
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systems upports the contention that the function of 
the P-galactoside-binding lectin present in myoblasts 
is prerequisite for fusion of the myoblasts [12,19, 
21,221. The role of this lectin in myotube formation 
is not understood. Because lectins with the same spe- 
cificity occur in a variety of tissues it has been sug- 
gested that the same lectin may have a different func- 
tion in different tissues [181, or that the lectin may 
have a common function which is expressed at dif- 
ferent times during development [4]. Despite these 
speculations, we have no understanding of the func- 
tion of thrombolectin in the Bothrops atrox venom. 
However, the fact that thrombolectin is present in 
venom of Bothrops atrox suggests hat binding of 
thrombolectin to receptors of galactolectins in animals 
bitten by Bothrops atrox may contribute to the death 
of the injured animal. This raises the possibility that 
the function(s) of galactolectins and/or their receptors 
is required for the viability of a variety of animals. 
Although, to our knowledge, this is the first report 
of a lectin isolated from a snake venom, there are 
other observations reported in the literature which 
may be explicable in these terms. A glycoprotein was 
isolated from the venom of the pit viper Tn’meresurus 
okinauensis [23]. This glycoprotein lacks caseinolytic, 
esterolytic and coagulant activities, yet it causes the 
aggregation f blood platelets. Similar activity was 
identified in the venoms of Crotalus terrificus and 
Trimeresunts purpureomaculuta [24]. A platelet 
aggregating a ent was identified in the venom of 
Gotalus horridus horridus [25]. Also, a coagglutinin 
for von Willebrand factor was identified in Bothrops 
venom [26]. As thrombolectin causes platelet aggre- 
gation (T. K. G., D. C. W., submitted) in each or some 
of the above examples, a lectin may be one of the 
platelet aggregating components present in the 
venoms. Further work is required to clarify this issue. 
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